Well Known Researcher Calls for More Studies on Alzheimer’s Disease

 

 

There are a few diseases that have puzzled medical researchers for long and one of them is Alzheimer’s Disease. According to conservative estimates, more than 36 million people across the globe suffer from this disease. As a matter of fact, there is growing concern about this disease which tends to mostly affect elderly people given that populations of many countries are aging rapidly. This is sure to put a lot of pressure on public health care systems in many countries while also resulting in societal problems unless a vaccine or a cure for it can be found.

According to widely famed scientist and biomedical researcher Dr.Micheal Mullen, one of the biggest problems is that this disease does not get the attention that it deserves even though it poses huge problems. As President and CEO of the Roskamp Institute which is located in Sarasota Florida, he leads a team of dedicated researchers who have been at the forefront of the research to understand this disease. He certainly knows what he is talking about when he says that the disease needs to be understood better. Dr. Mullen, a physician trained in London, is also a renowned geneticist who has published many papers on Alzheimer’s and other long term degenerative diseases that affect the brain.

One of the biggest problems faced by Alzheimer’s researchers is the serious lack of funding. This has got something to do with the fact that trials for this disease take inordinately long. It is an unfortunate fact that the cost of the trials goes up in direct proportion to the time it takes. In fact, there are at least a hundred trails for cancer for every trial conducted for Alzheimer's disease. Besides, clinical trials for this disease are not easy to conduct.

Another factor to be considered is that most research on Alzheimer’s focuses on the levels of a protein called Amyloid in late stage Alzheimer’s patients. It is the accumulation of this protein in the brain which is known to cause the onset of the disease. However, since very little research studies its levels at the early stages or even before the onset of the disease, there is still very little understanding of the disease. Michael Mullan has maintained that this small but significant protein merits further study as do other early markers of Alzheimer’s disease.

There is absolutely no doubt about the fact that the Alzheimer’s research community is woefully underfunded. It is only when it gets government and private funding in the required quantum that researchers will be able to get plenty of breakthroughs about this disease. In the meanwhile, physicians and researchers alike eagerly await the results of studies conducted at places like the Roskamp Institute.

Source: http://michaelmullanbiomedicalresearche.wordpress.com/

Institute in Quest of Solution to Genetic Disorders

 

Michael Mullan

Extensive research is being done on Molecular Genetics in quest for finding a solution to diseases that result from Nero degenerative disorders like Alzheimer. Continuous studies made by eminent physicians holding doctorate degree and invaluable support from various institutes have kindled the hope of finding a way to combat these disorders in a successful way.

Role of Institute

There are institutes which are dedicated in finding a cure for neuro degenerative disorders including addictions and also by putting great emphasis on Alzheimer’s disease. The Roskamp Institute is one of them where wide range of innovative methodologies are being used which are scientifically designed to study the deep rooted causes of these neuro disorders and find a positive way for cure through effective and safe drug therapies. Research work carried out at these institutes is aimed at discovering treatments for helping people to age through healthy ways.

Qualities of research workers

Those involved in the research work include medical professionals having PhD in various subjects like Michael Mullan who is a doctorate in Philosophy. Some of the research workers attached with the Institute are award winners for their excellence in Genetic studies and are dedicated towards finding the best and safe ways of arresting problems related to neuro disorders. Interdisciplinary scientists with high experience are engaged in research work at this institute where you will find a state of the art infra structure which include modern labs for research and latest equipments to conduct them.

The Roskamp Institute

Led by Dr. Michael Mullan, The Roskamp Institute started in a humble way building specialized homes for disabled adults affected by emotional disorders and from there on continuous studies for finding cures for these diseases are being undertaken. Relentless effort by scientists and highly qualified technicians have made it possible to establish this institute as a global leader in understanding the deep rooted causes of these debilitating mental disorders and effective ways for finding a solution for their cure. It is at this institute that cutting edge research technologies are applied to fight the causes of various neurological problems with special emphasis on Alzheimer’s disease.  Located in Sarasota, Florida, The Roskamp Institute utilizes broad ranging scientific approaches which are advanced and aimed at finding potential therapies. Novel methods of treatment for Neurodegenerative and Neuropsychiatric disorders have been found by this institute which are on clinical trials.   Led by CEO Dr. Michael Mullan researcher, this institute specializes in research work on various areas.

Areas of research work

Under the table guidance of the President of the institute, research work with cutting edge technologies are conducted on diseases like:

·         Head Trauma

·         Toilette’s Syndrome

·         Cancer

·         Drug addiction and other disorders of the neurological structure of our body.

Funded by general people, this institute welcomes donations for aiding their research work which promises to be result oriented in finding effective ways for treatment of these nervous disorders. All donations to this institute are tax deductible under the Income Tax Law.

 

Michael Mullan Researcher

Fighting Alzheimer’s and Other Such Brain Diseases with Dr. Michael Mullan

Dr. Michael Mullan is a great biomedical researcher working in the field of B-amyloid protein and their active relations with the deadly disease of Alzheimer’s. Alzheimer’s disease or as it is also known as Alzheimer’s dementia is a very common form of dementia or memory loss, which is incurable till now and the person suffering from it losses all its memories with the progression of disease, worsening the condition of the patient and eventually the patient dies. Since this disease is usually diagnosed in people over 65 years of age, this was thought to be an age related problem earlier. But with time more and more cases were reported at a very early stage of life.

It was the scientists at Roskamp Institute, who found the first solid evidence of this disease being genetic more than 20 years ago. Michael Mullan was the director of Roskamp Institute since 1994 when it was founded in Sarasota and now is the president and the CEO of the Roskamp Institute. He was born in Kent, in a place known as Farnborough in 1956 and started working at Royal Free Hospital and Friern Hospital while studying at the Royal College of Psychiatrists in 1988. He learned about many fields of researches and worked in many to strengthen his interest in the field of geriatric psychology. He has been held accountable for many responsibilities and positions in so many years that includes senior registrar in Psychiatry and also had been an Honorary Clinical Research Registrar at the Masonic Hospital in the Department of Psychological Medicine there.

With his caliber and research he has touched all heights in the field of Alzheimer’s disease research. He holds about a dozen patents and hundreds of research publications on his name. He has been publishing exclusive research on the molecular genetics and Alzheimer’s disease and also on the focus points of the neuropathology of dementia and role and effects of alcoholism. He also wrote about the manic depression and disease schizophrenia as a contribution to a scientific magazine.

 Michael Mullan Sarasota

Michael Mullan Biomedical Researcher collaborating with a team of neuroscientist at the Roskamp Institute founded by Bob Roskamp invented the Brain Reserve Index which is a numerical index that indicates and predicts risk of developing Alzheimer's disease in a person.  He was the one to find a connection between amyloid accumulations and triggering of chained events that leads to degeneration of brain cells and declination of cognitive that is on set of the Alzheimer’s disease. Based on this study he developed some transgenic mice which act as a model of early onset of Alzheimer’s disease in humans. With these mice model based studies, new drugs were developed to control and fight this disease. It is quite known that the disease Alzheimer does not only destroys a person’s life but also shatters the family of that person. Because before dying it takes away all the cherished memories of that person killing his social and family life too. But with the efforts of Michael Mullan Roskamp Institute much have been developed in the field of this science and with his ongoing efforts and research it is quite possible that we get a cure to this disease very soon.

Interested In Knowing About The Advanced Research Done By Dr. Michael Mullan On Alzheimer

Michael Mullan is an MBBS and PhD degree holder, who has published many papers related to neurological science. He was the senior author of the book “Nature and Nature Genetics”, that represented the mutations in Amyloid Precursor Protein, often abbreviated as APP, which is the root cause of Alzheimer’s disease. With his colleague Dr. Fiona Crawford, he discovered the “Swedish” mutation in APP Gene, which further led to the development of first animal model for Alzheimer’s disease (AD). He has worked with several prestigious medical institutes, and even established the Roskamp Institute, dedicated completely towards finding treatments for neurological disorders.

Michael Mullan Roskamp Institute

Mullan is a well-known scientific researcher who has dedicated his life towards finding better treatments for disorders linked with brain. Several of the papers published by him have been concluded after deep study of different subjects. Michael Mullan Sarasota dreams to find the cure to the most sophisticated brain disorders in the world, to give a new life to patients suffering from these kinds of disease. For this purpose, he not only runs a special institute, but even directs a memory center which conducts clinical evaluations on patients. He is also engaged in several governments as well as private industry sponsored clinics.

Dr. Mullan established his Rockamp Institute in Sarasota, Florida. The institute is not only focused on research on Alzheimer’s, but also experiments on Traumatic Brain, Gulf War Illness, and various other neurological disorders. The current research areas include Inflaming, Traumatic Brain Injury, Drug Discovery for Neurodegenerative disorders and Gulf War Syndrome. The research conducted by Dr. Muller on Alzheimer’s, has given him a good reputation in the medical community. He basically studied the relationship between beta-amyloid with Alzheimer’s to provide revolutionary results.

Michael Mullan Biomedical Researcher has recently published a report on traumatic brain injuries. The report throws quite a good light on the relationship between head injuries and Alzheimer’s. He has carefully scrutinized the American footballers to determine the close links between declines in cognitive abilities and repeated concussion. Studies show that moderate and severe diseases are related to AD, and full recovery of cognitive loss can be easily regained after mild TBI i.e. Traumatic Brain Injury. Another study involves the relationship between time of injury, and the development of subsequent dementia. In a study of large populations, conclusions have been made that TBI at old age is worse as compared to TBI at a younger age

Another question that has been answered by his research is how the brain remembers signs of injury after so many years without even showing any signs of cognitive loss. Once all the puzzles and riddles hidden beneath AD and TBI are sorted out, it would provide new targets for prevention of AD following TBI. Another area which demands attention is the risk of poor recovery after an efficient TBI Technique and subsequent risk for AD in the coming future. A bit of more work is certainly needed in this field, but when the final conclusions are made, the day would be no less than a complete revolutionary day in the history of mankind.